Skip to content
S3541Senate2023-2024 Session

Relates to designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies

Sponsor Neil D. BreslinSD-46Affects Education
Status
In Senate Committee
Higher Education
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

Summary being written. Track this bill to get it by email.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Sponsors

Primary sponsor
Neil D. Breslin

Senator · Senate District 46

Chair, Ethics And Internal GovernanceChair, Insurance

No co-sponsors yet.

History

  1. Referred to higher education
  2. Referred to higher education

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

3541

2023-2024 Regular Sessions

IN SENATE

January 31, 2023

Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education

AN ACT to amend the education law, in relation to designated suppliers and authorized distributors of nonprescription blood glucose selftesting equipment, devices and supplies

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The education law is amended by adding a new section 6808-c to read as follows:

§ 6808-c. Suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies. 1. As used in this section, "nonprescription blood glucose self-testing equipment, devices and supplies" means blood glucose monitors, continuous glucose monitors (CGM), blood glucose test strips, lancet devices and lancets, glucose control solutions for checking the accuracy of testing equipment and test strips, supply allowance for therapeutic continuous glucose monitors (CGM), including all supplies and accessories for use in the treatment of prediabetic or diabetic individuals that may be sold without a prescription and are labeled for use by the consumer in accordance with the requirements of the laws and rules of this state and the federal government.

2. Within one hundred eighty days of the effective date of this section, each manufacturer of nonprescription blood glucose self-testing equipment, devices and supplies shall submit to the state board of pharmacy a comprehensive list of designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies. Such manufacturers shall update the state board of pharmacy when there are any changes to the list of designated suppliers and authorized distributors. Within ninety days of receiving that information, such board shall post the names of designated suppliers and authorized distributors on the department's website.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03947-01-3

3. It shall be unprofessional conduct for a pharmacist to:

a. dispense nonprescription blood glucose self-testing equipment, devices and supplies received from a person or entity that the pharmacist knew or reasonably should have known was not a manufacturer's designated supplier or authorized distributor; or

b. submit a reimbursement claim for nonprescription blood glucose self-testing equipment, devices and supplies to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the pharmacist knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription blood glucose self-testing equipment, devices and supplies manufacturer's designated supplier or authorized distributor.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to designated suppliers and authorized distributors of nonprescription blood glucose self-test- ing equipment, devices and supplies

Summary of specific provisions

Section 1 adds a new section 6808-c to create a definition for nonpres- cription blood glucose self-testing equipment, devices, and supplies and requires manufacturers to submit a list of designated supplies and authorized distributors to the New York State Board of Pharmacy to post publicly on the NYS Education Department website and to keep the list updated as changes occur. The new section also finds that it shall be unprofessional conduct for a pharmacist to dispense nonprescription blood glucose self-testing equipment, devices, and supplies that they knew or reasonably should have known are not from a designated supplier or authorized distributor or to submit a reimbursement claim for such nonprescription blood glucose self-testing equipment, devices, and supplies if the pharmacist knew or reasonably should have known that the device was not purchased from a designated supplier or authorized distributor.

Section 2 provides for an immediate effective date.

Justification

When using diabetes testing devices, supplies, and equipment (i.e. Blood Glucose Testing Supplies (BGTS) or Continuous Glucose Monitoring (CGM)), patients make therapeutic decisions based on prescribers proto- cols to manage diabetes. These decisions result in changes in dosing of insulin by as little as 1-2 units of insulin and an incorrect adjustment can lead to hypoglycemia or hyperglycemia, negatively impacting a patient's health. Consistency of product is crucial in overall diabetes management.

It has been widely reported regarding the growth of the illicit market for diabetes testing supplies and equipment, especially glucose strips. The Albany Times Union in 2012 cited a growing diabetic population fuel- ing the underground market. In April 2019, the U.S. Food and Drug Administration issued a safety alert warning that sellers are marketing preowned test strips or test strips not authorized for sale in the United State leading to inaccurate test results, infections, and increased risk of serious patient injury, including death.

This bill seeks to address this issue by providing information regarding authorized distributors and designated suppliers on the NYS Education Department website to allow ease of access to the information and to provide penalties in the event that a pharmacist chooses to sell diabetes testing equipment that is not from a designated supplier or authorized distributor. This is an important consumer protection and safety issue that will protect those who are managing diabetes, an ever growing population.

Prior legislative history

2019-2020: S.5403 Referred to Higher Education

2021-2022: S.5667

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.